Frederic Guerard work email
- Valid
- Valid
- Valid
- Valid
Frederic Guerard personal email
- Valid
Frederic Guerard phone numbers
Public company CEO with 20 years of experience in the Pharmaceutical industry. Raised over $150M between IPO and series C.Initiated and successfully implemented major strategic transformations in country, regional and global roles. Agile and outcome-driven, consistently delivered superior results during long-term assignments in the US, Europe, and Emerging countries. Track record of turnaround and sustainable performance through collaboration, vision, and high-performing teams. Scientific background and work experience in wide range of therapeutic areas including Ophthalmology, Oncology, Neurology, Cardiology, Respiratory, Rheumatology, Dermatology, and Immunology.
-
Non-Executive DirectorCalcimedicaUnited States -
Chief Executive OfficerOpthea Oct 2023 - PresentSouth Yarra, Vic, AuOpthea (ASX:OPT; Nasdaq:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). -
Non-Executive DirectorCalcimedica Mar 2023 - PresentLa Jolla, California, UsCalciMedica (Nasdaq: CALC) is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need
-
Non-Executive DirectorSpiral Therapeutics Mar 2023 - PresentSouth San Francisco, Ca, UsSpiral Therapeutics is a clinical-stage company focused on delivering therapies for inner-ear disorders such as Meniere's disease and hearing loss. -
Non-Executive DirectorLenz Therapeutics Sep 2021 - PresentSan Diego, California, UsLENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. LENZ lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia -
Chief Executive OfficerGraybug Vision, Inc. Feb 2019 - Mar 2023Graybug Vision (NASDAQ: GRAY) is a clinical stage pharmaceutical company developing novel products for the treatment of ocular diseases. The company’s proprietary injectable products are designed to enable less frequent administration to reduce the burden of treatment for patients and their physicians.
-
Worldwide Business Franchise Head OphthalmologyNovartis Apr 2016 - Jan 2019Basel, Baselstadt, ChLead the $5.3 billion, 6,000-associate, Ophthalmology franchise at Novartis which holds the #1 position globally across 125 countries and serves ~200 million patients per year. Novartis Ophthalmology franchise combines Novartis retina and Alcon Pharma portfolios. -
Global Franchise Head PharmaceuticalsAlcon, A Novartis Company May 2015 - Mar 2016Geneva, Switzerland, ChGlobal P&L responsibility (~$4 bn in 2015) for Pharmaceutical franchise -
Managing Director - Uk And IrelandNovartis Jul 2012 - Apr 2015Basel, Baselstadt, Ch
-
Country President And Managing Director - Australia And New ZealandNovartis Apr 2009 - Jul 2012Basel, Baselstadt, Ch
-
Head Of Commercial Operations - Emerging Growth MarketsNovartis Jan 2008 - Mar 2009Basel, Baselstadt, ChIn charge of Marketing, Sales, and Marketing and Sales Operations for Emerging Growth Markets (Africa, Middle East, Asia-Pacific)
-
Country President And Managing Director - EgyptNovartis Oct 2004 - Dec 2007Basel, Baselstadt, Ch
-
Head Of Export Business UnitNovartis Jul 2003 - Sep 2004Basel, Baselstadt, Ch
-
Marketing Manager, Export Business UnitNovartis Sep 2001 - Jun 2003Basel, Baselstadt, Ch
-
Cardiovascular Product ManagerNovartis Apr 1999 - Sep 2001Basel, Baselstadt, Ch
-
Board MemberThe Association Of The British Pharmaceutical Industry (Abpi) 2013 - 2015London, GbChairperson of the Health and Technology Assessment Strategy Group -
Board MemberMedicines Australia 2009 - 2012Deakin, Australian Capital Territory, AuBoard Sponsor of the Access Strategic CommitteeMember of the Finance and Audit Committee -
Product ManagerServier May 1997 - Mar 1999Suresnes, Fr
Frederic Guerard Skills
Frederic Guerard Education Details
-
Harvard School Of Public HealthExecutive Education -
Harvard Business SchoolExecutive Education Leadership
-
Harvard Business SchoolExecutive Education Finance
-
Hec ParisMarketing
-
Université De RouenMedical And Biological Sciences
-
Université De RouenPharmacy
Frequently Asked Questions about Frederic Guerard
What company does Frederic Guerard work for?
Frederic Guerard works for Calcimedica
What is Frederic Guerard's role at the current company?
Frederic Guerard's current role is Non-Executive Director.
What is Frederic Guerard's email address?
Frederic Guerard's email address is fr****@****con.com
What is Frederic Guerard's direct phone number?
Frederic Guerard's direct phone number is (800) 757*****
What schools did Frederic Guerard attend?
Frederic Guerard attended Harvard School Of Public Health, Harvard Business School, Harvard Business School, Hec Paris, Université De Rouen, Université De Rouen.
What skills is Frederic Guerard known for?
Frederic Guerard has skills like Pharmaceutical Industry, Market Access, Sales Effectiveness, Pharmaceutical Sales, Product Launch, Cross Functional Team Leadership, Oncology, Cardiology, Pharmaceutics, Clinical Development, Biotechnology, Diabetes.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial